Biogen to forestall promoting controversial Alzheimer’s drug Aduhelm
Biogen will stop constructing its Alzheimer’s treatment Aduhelm, a drug once viewed as a doable blockbuster earlier than stumbling rapidly after its start a pair years ago.
Read More
